Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find cure of human cancer using its cutting edge TCR-T technologies.
Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR hold great promise in treating patients unaddressed by current modalities.